Roma Yumul

1.2k total citations
28 papers, 968 citations indexed

About

Roma Yumul is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Roma Yumul has authored 28 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Genetics and 12 papers in Oncology. Recurrent topics in Roma Yumul's work include Virus-based gene therapy research (15 papers), CAR-T cell therapy research (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Roma Yumul is often cited by papers focused on Virus-based gene therapy research (15 papers), CAR-T cell therapy research (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Roma Yumul collaborates with scholars based in United States, France and Taiwan. Roma Yumul's co-authors include André Lieber, Yilong Cheng, Suzie H. Pun, Pascal Fender, Hongjie Wang, Ines Beyer, Maximilian Richter, Ruan van Rensburg, Sebastian Tuve and Kamola Saydaminova and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Nature Biotechnology.

In The Last Decade

Roma Yumul

28 papers receiving 950 citations

Peers

Countries citing papers authored by Roma Yumul

Since Specialization

Citations

This map shows the geographic impact of Roma Yumul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roma Yumul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roma Yumul more than expected).

Fields of papers citing papers by Roma Yumul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roma Yumul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roma Yumul. The network helps show where Roma Yumul may publish in the future.

Co-authorship network of co-authors of Roma Yumul

This figure shows the co-authorship network connecting the top 25 collaborators of Roma Yumul. A scholar is included among the top collaborators of Roma Yumul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roma Yumul. Roma Yumul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract C132: SGN-35T: A novel CD30-directed antibody-drug conjugate for the treatment of lymphomas 2023 ·Molecular Cancer Therapeutics ·Kevin J. Hamblett, (unknown), Roma Yumul, Yufei Chen, John H. Kwon, Jessica K. Simmons, Clark M. Henderson, Hao Sun, Jason Schrum, Andrea R. Lim, (unknown), Melissa Conerly, Astrid Clarke	2
2	Abstract 1522: SGN-B6A induces immunogenic cell death as an additional mechanism of action 2023 ·Cancer Research ·(unknown), (unknown), John J. Gosink, Michelle Ulrich, (unknown), (unknown), (unknown), Liya Huang, Kelly Hensley, Piper M. Treuting, Kerry Klussman, (unknown), (unknown), Roma Yumul, (unknown), Robert P. Lyon	2
3	SGN-B6A: A New Vedotin Antibody–Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma Indications 2023 ·Molecular Cancer Therapeutics ·Robert P. Lyon, Mechthild Jonas, Christopher Frantz, Esther S. Trueblood, Roma Yumul, Lori Westendorf, (unknown), Jackie L. Stilwell, (unknown), (unknown), Vineet Kumar, Gabriela I. Patilea‐Vrana, Kerry Klussman, Maureen C. Ryan	12
4	A coiled-coil masking domain for selective activation of therapeutic antibodies 2019 ·Nature Biotechnology ·(unknown), Xinqun Zhang, Roma Yumul, Weiping Zeng, Ivan J. Stone, (unknown), (unknown), Julia H. Cochran, Jessica K. Simmons, Maureen C. Ryan, Robert P. Lyon, Peter D. Senter, Matthew R. Levengood	64
5	Junction opener protein increases nanoparticle accumulation in solid tumors 2018 ·Journal of Controlled Release ·(unknown), Roma Yumul, (unknown), Yilong Cheng, André Lieber, Suzie H. Pun	21
6	Human adenovirus type 17 from species D transduces endothelial cells and human CD46 is involved in cell entry 2018 ·Scientific Reports ·Jing Liu, Philip Boehme, Wenli Zhang, Jun Fu, Roma Yumul, Kemal Mese, (unknown), Manish Solanki, Michael Kaufmann, Ruirui Lu, Achim Schmidtko, Aengus Stewart, André Lieber, Anja Ehrhardt	11
7	Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy 2017 ·Journal of Virology ·(unknown), Jens-Martin Hübner, Peter G. Beidler, Sucheol Gil, Kamola Saydaminova, Zhuozhuang Lu, Roma Yumul, Hongjie Wang, Maximilian Richter, Pavel Sova, Charles W. Drescher, Pascal Fender, André Lieber	19
8	In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors 2016 ·Blood ·Maximilian Richter, Kamola Saydaminova, Roma Yumul, (unknown), Jing Liu, (unknown), Manvendra Singh, Zsuzsanna Izsvák, Roberto Cattaneo, Wolfgang Uckert, Donna Palmer, Philip Ng, Kevin G. Haworth, Hans‐Peter Kiem, Anja Ehrhardt, Thalia Papayannopoulou, André Lieber	84
9	Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic 2016 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Roma Yumul, Kamola Saydaminova, Hongjie Wang, Michael J. Gough, Audrey Baldessari, Roberto Cattaneo, Frank Lee, (unknown), Haishan Jang, Anne Astier, Ajay K. Gopal, Darrick Carter, André Lieber	14
10	Virus‐Inspired Polymer for Efficient In Vitro and In Vivo Gene Delivery 2016 ·Angewandte Chemie International Edition ·Yilong Cheng, Roma Yumul, Suzie H. Pun	115
11	Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin 2015 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Roma Yumul, Hongjie Wang, Kamola Saydaminova, (unknown), (unknown), Audrey Baldessari, Michael J. Gough, Charles W. Drescher, Nicole Urban, Steve R. Roffler, Chloé Zubieta, Darrick Carter, Pascal Fender, André Lieber	23
12	Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs 2012 ·Clinical Cancer Research ·Ines Beyer, Hua Cao, Jonas Persson, (unknown), (unknown), Qinghua Feng, Roma Yumul, Ruan van Rensburg, Zongyi Li, Ronald Berenson, Darrick Carter, Steve R. Roffler, Charles W. Drescher, André Lieber	53
13	Transient Removal of CD46 Is Safe and Increases B-cell Depletion by Rituximab in CD46 Transgenic Mice and Macaques 2012 ·Molecular Therapy ·Ines Beyer, Hua Cao, Jonas Persson, Hongjie Wang, Ying Liu, Roma Yumul, Zongyi Li, (unknown), Ronald Manger, Michael J. Gough, (unknown), (unknown), Audrey Baldessari, Ronald Berenson, Darrick Carter, André Lieber	20
14	A New Human DSG2-Transgenic Mouse Model for Studying the Tropism and Pathology of Human Adenoviruses 2012 ·Journal of Virology ·Hongjie Wang, Ines Beyer, Jonas Persson, (unknown), Zongyi Li, Maximilian Richter, Hua Cao, Ruan van Rensburg, Xiaoying Yao, Kelly L. Hudkins, Roma Yumul, Xiao‐Bing Zhang, Mujun Yu, Pascal Fender, Akseli Hemminki, André Lieber	46
15	Epithelial Junction Opener JO-1 Improves Monoclonal Antibody Therapy of Cancer 2011 ·Cancer Research ·Ines Beyer, Ruan van Rensburg, Robert Strauss, Zongyi Li, Hongjie Wang, Jonas Persson, Roma Yumul, Qinghua Feng, (unknown), Jiří Bártek, Pascal Fender, André Lieber	69
16	Immuno-Therapy with Anti-CTLA4 Antibodies in Tolerized and Non-Tolerized Mouse Tumor Models 2011 ·PLoS ONE ·Jonas Persson, Ines Beyer, Roma Yumul, Zong-Yi Li, Hans‐Peter Kiem, Steve R. Roffler, André Lieber	13
17	Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models 2011 ·Cancer Gene Therapy ·(unknown), Sebastian Tuve, Jonas Persson, Ines Beyer, Roma Yumul, (unknown), Khajornsak Tragoolpua, K E Hellström, Steve R. Roffler, André Lieber	24
18	Controlled Extracellular Matrix Degradation in Breast Cancer Tumors Improves Therapy by Trastuzumab 2010 ·Molecular Therapy ·Ines Beyer, Zongyi Li, Jonas Persson, Ying Liu, Ruan van Rensburg, Roma Yumul, Xiao‐Bing Zhang, Mien‐Chie Hung, André Lieber	61
19	In situ adenovirus vaccination engages T effector cells against cancer 2009 ·Vaccine ·Sebastian Tuve, Ying Liu, Khajornsak Tragoolpua, Jeffrey Jacobs, Roma Yumul, Zong-Yi Li, Robert Strauss, K E Hellström, Mary L. Disis, Steve R. Roffler, André Lieber	37
20	Role of Cellular Heparan Sulfate Proteoglycans in Infection of Human Adenovirus Serotype 3 and 35 2008 ·PLoS Pathogens ·Sebastian Tuve, Hongjie Wang, Jeffrey Jacobs, Roma Yumul, David F. Smith, André Lieber	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact